Neurocrine Biosciences Presents at SG Cowen Annual Health Care Conference
SAN DIEGO, March 18 /PRNewswire-FirstCall/ -- Neurocrine Biosciences, Inc. (Nasdaq: NBIX) announced that the Company will present at the SG Cowen 23rd Annual Health Care Conference today, Tuesday, March 18, 2003 at 1:15 PM Eastern Standard Time; 10:15 AM Pacific Standard Time. The presentation will be simultaneously webcast and can be accessed on the Neurocrine website at http://www.neurocrine.com . Viewers are encouraged to visit the Company's website approximately 5 minutes prior to the presentation to download or install any necessary audio software.
Gary Lyons, President and CEO of Neurocrine will discuss indiplon, the Company's Phase III clinical development program for the treatment of insomnia.
If you are unable to attend the webcast and would like further information on this announcement please contact the Investor Relations Department at Neurocrine Biosciences at (858) 658-7600 and ask for Claudia Jones or Elizabeth Foster. A replay will become available approximately 1 hour after the live webcast. The presentation will be archived until Tuesday, April 1, 2003.
Neurocrine Biosciences, Inc. is a product-based biopharmaceutical company focused on neurological and endocrine diseases and disorders. Our product candidates address some of the largest pharmaceutical markets in the world including insomnia, anxiety, depression, malignant brain tumors and peripheral cancers, diabetes, multiple sclerosis, irritable bowel syndrome, eating disorders, pain, stroke, and certain female health disorders.
Neurocrine Biosciences, Inc. news releases are available through the Company's website via the Internet at http://www.neurocrine.com .
Contact: Claudia Jones at 858-658-7600.
SOURCE Neurocrine Biosciences, Inc.